Goyal Arjun

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Goyal Arjun
CIK #0001861844
EDGAR Form CIK 2011 - 2026
3 [0001861844]
4 [0001861844]
Form 3/4/5 Subject 2011 - 2026
Centessa Pharmaceuticals PLC
Goyal Arjun
JATT II Acquisition Corp
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Centessa Pharmaceuticals PLC CNTA
Share Option (right to buy) · derivative
2025-06-20 Grant 40,000 $0.00
Centessa Pharmaceuticals PLC CNTA
Ordinary Shares
2025-05-16 Buy 417,646 $12.73 5,316,634
Centessa Pharmaceuticals PLC CNTA
Ordinary Shares
2025-05-15 Buy 44,939 $12.24 550,053
Centessa Pharmaceuticals PLC CNTA
Share Option (right to buy) · derivative
2024-06-25 Grant 48,000 $0.00
Centessa Pharmaceuticals PLC CNTA
Share Option (right to buy) · derivative
2023-06-22 Grant 48,000 $0.00
Centessa Pharmaceuticals PLC CNTA
Share Option (right to buy) · derivative
2022-06-30 Grant 48,000 $0.00
Centessa Pharmaceuticals PLC CNTA
Share Option (right to buy) · derivative
2021-07-01 Grant 64,570 $0.00
Centessa Pharmaceuticals PLC CNTA
Ordinary Shares
2021-06-02 Buy 20,250 $20.00 405,000
Centessa Pharmaceuticals PLC CNTA
Ordinary Shares
2021-06-02 Conversion 3,095,909
Centessa Pharmaceuticals PLC CNTA
Ordinary Shares
2021-06-02 Buy 729,750 $20.00 14,595,000
Centessa Pharmaceuticals PLC CNTA
Ordinary Shares
2021-06-02 Conversion 85,909
Centessa Pharmaceuticals PLC CNTA
Series A Preferred Shares · derivative
2021-06-02 Conversion 3,095,909 $0.00
Centessa Pharmaceuticals PLC CNTA
Series A Preferred Shares · derivative
2021-06-02 Conversion 85,909 $0.00
Centessa Pharmaceuticals PLC CNTA
Series A Preferred Shares · derivative
2021-01-29 Grant 85,909 $11.00 944,999
Centessa Pharmaceuticals PLC CNTA
Series A Preferred Shares · derivative
2021-01-29 Grant 3,095,909 $11.00 34,054,999
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com